HQY Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
HealthEquity Inc (HQY) is a good buy for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The company's strong financial performance, positive analyst sentiment, and growth opportunities in the health savings account market outweigh the current hedge fund selling trend and lack of immediate trading signals.
The MACD is positively expanding, indicating bullish momentum. RSI is neutral at 61.892, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its resistance level of 84.672, with key support at 81.17. Overall, the technical indicators suggest moderate bullish potential.
Strong Q4 financial performance with revenue up 7.30% YoY, net income up 88.66% YoY, and EPS up 93.33% YoY.
Positive analyst sentiment with multiple upgrades and raised price targets, highlighting growth opportunities in the health savings account market and the company's Marketplace launch.
The stock has a 70% chance of increasing 4.89% in the next month based on historical candlestick patterns.
Hedge funds are selling, with a 213.73% increase in selling over the last quarter.
Bearish moving averages suggest caution in the short term.
No recent congress trading data or significant insider activity to indicate strong internal confidence.
In Q4 2026, HealthEquity reported revenue of $334.59M (+7.30% YoY), net income of $49.74M (+88.66% YoY), EPS of $0.58 (+93.33% YoY), and gross margin of 60.13% (+15.70% YoY). These results demonstrate strong growth and profitability.
Analysts are broadly positive on HQY, with recent upgrades and raised price targets. BMO Capital upgraded the stock to Outperform with a price target of $105, citing growth opportunities and overblown AI fears. Deutsche Bank raised its price target to $128, highlighting strong execution. Other analysts maintain Buy or Outperform ratings, with price targets ranging from $100 to $128, reflecting confidence in the company's long-term growth prospects.
